Caspofungin Acetate in Treating Children With Fever and Neutropenia
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving caspofungin acetate may be effective in preventing or controlling fever and
neutropenia caused by chemotherapy or bone marrow transplantation.
PURPOSE: Clinical trial to study the effectiveness of caspofungin acetate in treating
children who have fever and neutropenia caused by a weakened immune system.